Eli Lilly announced plans to manufacture its new weight loss pill, orforglipron, in the U.S., with global distribution set to begin in 2026, Bloomberg reported April 18. The move comes as President Donald Trump presses companies to shift to domestic production. "We're going to make this medicine here in the United States," CEO Dave Ricks [...] The post Eli Lilly to make weight loss pill in US appeared first on Becker's Hospital Review | Healthcare News & Analysis.
Lilly is a Massachusetts-based pharmaceutical company that develops, produces and markets pharmaceutical products for healthcare professionals, patients and consumers.